Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: MTB cfDNA Levels in TBP

View source ↗

Summary

A completed clinical trial investigating MTB cfDNA levels in pleural tuberculosis (NCT05397730) sponsored by the Chinese University of Hong Kong.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Tuberculosis, Pleural | Status: COMPLETED